Lesson plan

DA-Phen

DA-Phen, also known as dopamine–phenylalanine conjugate, is a synthetic dopamine prodrug which is under preclinical evaluation. Dopamine itself is hydrophilic and is unable to cross the blood–brain barrier, thus showing peripheral selectivity. DA-Phen was developed as a dopamine prodrug that would allow for entry into the central nervous system via passive diffusion and/or active transport. DA-Phen is a conjugate of dopamine and the amino acid phenylalanine (Phe or Phen). It is slowly cleaved by brain enzymes (t ½ = 460 minutes) to yield free dopamine but is also rapidly hydrolyzed in human blood plasma (t ½ = 28 minutes). The drug was intended as a prodrug but may also directly interact with the dopamine D 1 -like and/or D 2 -like receptors. DA-Phen has shown centrally mediated effects in animals, including increased cognitive flexibility, improved spatial learning and memory, antidepressant- and anxiolytic-like effects, and decreased ethanol intake. Other analogues, such as DA-Trp and DA-Leu, have also been developed and studied.

Back to article

Article summary

DA-Phen, also known as dopamine–phenylalanine conjugate, is a synthetic dopamine prodrug which is under preclinical evaluation. Dopamine itself is hydrophilic and is unable to cross the blood–brain barrier, thus showing peripheral selectivity. DA-Phen was developed as a dopamine prodrug that would allow for entry into the central nervous system via passive diffusion and/or active transport. DA-Phen is a conjugate of dopamine and the amino acid phenylalanine (Phe or Phen). It is slowly cleaved by brain enzymes (t ½ = 460 minutes) to yield free dopamine but is also rapidly hydrolyzed in human blood plasma (t ½ = 28 minutes). The drug was intended as a prodrug but may also directly interact with the dopamine D 1 -like and/or D 2 -like receptors. DA-Phen has shown centrally mediated effects in animals, including increased cognitive flexibility, improved spatial learning and memory, antidepressant- and anxiolytic-like effects, and decreased ethanol intake. Other analogues, such as DA-Trp and DA-Leu, have also been developed and studied.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.